Company intelligence / Profile preview

Biotopia

Chuncheon, Gangwon-do, South Korea

Ownership: Private
Employees: ~100
Development stage: Other

Overview

Biotopia focuses on high-efficiency microbial fermentation and synthetic biology to produce probiotics and functional feed additives. Their clinical focus centers on the efficacy of postbiotics and probiotics in improving gut health and modulating the immune system, with several products already commercially available in the food and animal health sectors.

Therapeutic areas: OtherImmunologyDermatologyGastroenterology
Modalities: Live biotherapeutic product therapySmall moleculeProteinPeptides
Industry: Non-Drug Biotech

Partnerships

CJ CheilJedangCJ Bio

Beyond the preview

Go deeper on Biotopia.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biotopia.

Explore the full profile